Fieldpoint Private Securities’s Genomic Health, Inc. GHDX Stock Holding History

Fieldpoint Private Securities’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-699	Closed	-$47K	–	740
2019 Q3	$47K	Sell	699 -62	-8%	-$4.26K	0.02%	398
2019 Q2	$44K	Buy	+761	New	+$45.1K	0.01%	440

Fieldpoint Private Securities's GHDX Position: Q4 2019 in Review

Fieldpoint Private Securities sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 699 shares — an estimated $47K sold.

Fieldpoint Private Securities first reported a position in GHDX in Q2 2019 and held it in 2 quarters. The position peaked at $47K in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Fieldpoint Private Securities reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Fieldpoint Private Securities sold 699 Genomic Health, Inc. shares in Q4 2019, an estimated $47K.
Fieldpoint Private Securities first reported a position in Genomic Health, Inc. in Q2 2019 and held it in 2 quarters.
Fieldpoint Private Securities's Genomic Health, Inc. position peaked at $47K in Q3 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Fieldpoint Private Securities's 13F filing for Q4 2019, filed 10 Feb 2020.